Onycho-tricho-dysplasia-neutropenia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2739OMIM:258360
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Onycho-tricho-dysplasia-neutropenia syndrome is an extremely rare genetic condition that affects the nails, hair, and immune system. The name breaks down as follows: 'onycho' refers to nails, 'tricho' refers to hair, and 'dysplasia' means abnormal development. 'Neutropenia' means a low count of neutrophils, which are white blood cells that help fight infections. People with this syndrome typically have abnormal or underdeveloped nails that may be thin, ridged, or poorly formed. Hair is often sparse, thin, or brittle, and may grow slowly. The low neutrophil count makes affected individuals more vulnerable to bacterial and fungal infections, which can range from mild skin infections to more serious illnesses. This condition is present from birth or early infancy. Because it is so rare, there is no specific cure, and treatment focuses on managing symptoms. This may include careful monitoring and treatment of infections, sometimes with preventive antibiotics, and supportive care for nail and hair problems. Growth factor medications such as G-CSF (granulocyte colony-stimulating factor) may be used to boost neutrophil counts in some patients. Regular follow-up with specialists is important to manage the various aspects of this syndrome.

Also known as:

Key symptoms:

Abnormal or poorly developed nailsThin, sparse, or brittle hairLow white blood cell count (neutropenia)Frequent or recurrent infectionsSlow nail growthRidged or misshapen nailsSlow hair growthSkin infectionsMouth sores or gum infectionsPossible delayed growth

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Onycho-tricho-dysplasia-neutropenia syndrome.

View clinical trials →

No actively recruiting trials found for Onycho-tricho-dysplasia-neutropenia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Onycho-tricho-dysplasia-neutropenia syndrome community →

No specialists are currently listed for Onycho-tricho-dysplasia-neutropenia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Onycho-tricho-dysplasia-neutropenia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Onycho-tricho-dysplasia-neutropenia syndromeForum →

No community posts yet. Be the first to share your experience with Onycho-tricho-dysplasia-neutropenia syndrome.

Start the conversation →

Latest news about Onycho-tricho-dysplasia-neutropenia syndrome

No recent news articles for Onycho-tricho-dysplasia-neutropenia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's neutropenia, and how often should blood counts be checked?,Should my child take preventive antibiotics or G-CSF injections?,What signs of infection should I watch for, and when should I go to the emergency room?,Is genetic testing available to confirm the diagnosis and help with family planning?,Are there any activities or environments my child should avoid to reduce infection risk?,What can be done to help with the nail and hair problems?,Are there any clinical trials or new treatments being studied for this condition?

Common questions about Onycho-tricho-dysplasia-neutropenia syndrome

What is Onycho-tricho-dysplasia-neutropenia syndrome?

Onycho-tricho-dysplasia-neutropenia syndrome is an extremely rare genetic condition that affects the nails, hair, and immune system. The name breaks down as follows: 'onycho' refers to nails, 'tricho' refers to hair, and 'dysplasia' means abnormal development. 'Neutropenia' means a low count of neutrophils, which are white blood cells that help fight infections. People with this syndrome typically have abnormal or underdeveloped nails that may be thin, ridged, or poorly formed. Hair is often sparse, thin, or brittle, and may grow slowly. The low neutrophil count makes affected individuals more

How is Onycho-tricho-dysplasia-neutropenia syndrome inherited?

Onycho-tricho-dysplasia-neutropenia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Onycho-tricho-dysplasia-neutropenia syndrome typically begin?

Typical onset of Onycho-tricho-dysplasia-neutropenia syndrome is neonatal. Age of onset can vary across affected individuals.